The LRG is here to help, join our community of patients, caregivers and specialists!
We have the latest in GIST news and research to help manage your treatment!
We are accepting applications to be listed among our GIST Specialists.
The Latest News from the Life Raft Group
A new tool is now available for calculating the risk of GIST recurrence. The GIST Risk Calculator is based on research from Dr. Heikki Joensuu, Professor of Oncology at the University of Helsinki and the Research Director at the Helsinki Comprehensive Cancer Center, and his colleagues. The study drew from an international sample of 2000 […]
On February 1, 2016, there was a commercial launch of the generic version of imatinib mesylate (Gleevec) which is approved for CML patients by the FDA. As the first to file for generic marketing in the US, Sun Pharmaceuticals was given a 6-month market exclusivity, and it has since expired in August 2016. There are […]
The following are summaries of two of the Wild Type GIST parallel track sessions at Life Fest, 2016, submitted by Rebecca Bensenhaver of GSI International. “I was fortunate to be able to attend Life Fest 2016. There were many interesting presentations given during the conference. In an effort to pass the information on to those not in […]